Sema3d restrained the progression of hepatocellular carcinoma proliferation, invasion, and metastasis through inactivating Pi3k/Akt, which may serve as a novel prognostic predictor and a potential therapeutic target for HCC patients. This evidence concerns the gene AKT1 and hepatocellular carcinoma.